Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 13, Issue 1, Pages 121-135
Publisher
Informa Healthcare
Online
2012-11-30
DOI
10.1517/14712598.2013.748030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
- (2012) S. Mannino et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
- (2012) Terho Heikkinen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
- (2012) E. Caproni et al. JOURNAL OF IMMUNOLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
- (2012) Markku Partinen et al. PLoS One
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- Influenza: Options to Improve Pandemic Preparation
- (2012) R. Rappuoli et al. SCIENCE
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- The Potential for Respiratory Droplet-Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host
- (2012) C. A. Russell et al. SCIENCE
- Emergence of Fatal Avian Influenza in New England Harbor Seals
- (2012) S. J. Anthony et al. mBio
- Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects
- (2012) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
- (2011) Jiri Beran et al. CLINICAL THERAPEUTICS
- H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy
- (2011) J.-F. Rahier et al. GUT
- Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations
- (2011) Angelika Banzhoff et al. Human vaccines & immunotherapeutics
- Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA
- (2011) Erin E. Verity et al. Influenza and Other Respiratory Viruses
- Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009
- (2011) Gulam Khandaker et al. Influenza and Other Respiratory Viruses
- Combined, Concurrent, and Sequential Administration of Seasonal Influenza and MF59-Adjuvanted A/H5N1 Vaccines: A Phase II Randomized, Controlled Trial of Immunogenicity and Safety in Healthy Adults
- (2011) Pio Lopez et al. JOURNAL OF INFECTIOUS DISEASES
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
- (2011) Timo Vesikari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
- (2011) Steven Black et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination
- (2011) Darius Soonawala et al. PLoS One
- Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
- (2011) Theodore F. Tsai et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination
- (2011) Elisabetta Parretta et al. VACCINE
- Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district
- (2011) Cristina Cristiani et al. VACCINE
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents
- (2011) Susanna Esposito et al. VACCINE
- Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children
- (2011) Sara Meier et al. VACCINE
- Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
- (2011) Timo Vesikari et al. VACCINE
- Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
- (2011) Ori Elkayam et al. ARTHRITIS CARE & RESEARCH
- A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly
- (2010) E. Fragapane et al. Clinical and Vaccine Immunology
- Vaccinate before the next pandemic?
- (2010) Klaus Stöhr NATURE
- An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients
- (2010) S. Esposito et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
- (2010) T. Vesikari et al. PEDIATRICS
- Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence
- (2010) C. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis
- (2010) Steven Black et al. VACCINE
- Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data
- (2009) Geert Leroux-Roels EXPERT OPINION ON BIOLOGICAL THERAPY
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T-cell immunosenescence: lessons learned from mouse models of aging
- (2009) Alexander C. Maue et al. TRENDS IN IMMUNOLOGY
- Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
- (2009) Isabella Alberini et al. VACCINE
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- Exposure to MF59-adjuvanted influenza vaccines during pregnancy—A retrospective analysis
- (2009) Theodore Tsai et al. VACCINE
- Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
- (2009) Surender Khurana et al. PLOS MEDICINE
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1
- (2008) Iain Stephenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of MF59™ adjuvant
- (2008) Viola Schultze et al. VACCINE
- HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines
- (2008) J.C. Kapteyn et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started